A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy. (Q45928395)
Jump to navigation
Jump to search
scientific article published on 15 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy. |
scientific article published on 15 July 2009 |
Statements
1 reference
A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy. (English)
1 reference
Y Segawa
1 reference
K Aogi
1 reference
K Inoue
1 reference
M Sano
1 reference
I Sekine
1 reference
Y Tokuda
1 reference
H Isobe
1 reference
T Ogura
1 reference
M Tsuboi
1 reference
S Atagi
1 reference
PALO Japanese Cooperative Study Group
1 reference
15 July 2009
1 reference
1 reference
20
1 reference
11
1 reference
1874-1880
1 reference
Identifiers
1 reference
1 reference